Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Thursday, 18 May 2017

DNA to start repurchase of its own shares

DNA Oyj    

Published: 11:00 CEST 18-05-2017 /GlobeNewswire /Source: DNA Oyj / : DNA /ISIN: FI4000062385

DNA to start repurchase of its own shares

DNA PLC STOCK EXCHANGE RELEASE 18 MAY 2017, 12:00 pm EET

DNA Plc starts repurchase of its own shares in connection with the company's incentive schemes.

DNA Plc's Board of Directors has decided in its meeting on 18 May 2017 to use the authorisation given by the Annual General Meeting held on 22 March 2017 to acquire DNA's shares and initiate a share repurchase programme. The repurchase of shares is carried out in order to fulfil obligations pertaining to the company's share-based incentive schemes.

The repurchasing of shares will start on 1 June 2017 at the earliest, and end at the latest at the closing of the next Annual General Meeting in 2018, at the latest on 30 June 2018. The maximum number of shares to be repurchased is 1,000,000, which corresponds to approximately 0.76 per cent of the total number of DNA shares at the moment. A maximum sum of EUR 14 million can be spent on the repurchase programme.

The number of repurchased shares may not exceed 25 per cent of the average daily volume of trade in DNA's shares. The average daily volume is based on the average daily volume of the month preceding the publication month of this release.

The company's own shares are repurchased in proportions not corresponding to the shareholders' holdings, using the company's unrestricted shareholders' equity. The shares will be purchased at the market price prevailing on the day of the repurchase on the regulated market organised by Nasdaq Helsinki Ltd.

DNA's Board of Directors is authorised by the Annual General Meeting of 22 March 2017 to repurchase a maximum of 2,500,000 shares in one or several tranches. The authorisation is valid until the end of the Annual General Meeting of 2018. DNA does not currently hold any own shares.

Further enquiries:
Investor relations, Marja Mäkinen, tel. +358 44 044 1262, marja.makinen@dna.fi
DNA Corporate Communications, tel. +358 44 044 8000, viestinta@dna.fi

Distribution:
Nasdaq Helsinki
Key media
www.dna.fi 

DNA Plc is a Finnish telecommunications group providing high-quality voice, data and TV services for communication, entertainment and working. DNA is Finland's largest cable operator and the leading pay TV provider in both cable and terrestrial networks. For DNA, the key area for growth in corporate business is the new way of working, independent of time and place, facilitated by smart terminal devices, diverse communications services and rapid connections. In 2016, DNA recorded net sales of EUR 859 million and an operating profit of EUR 91 million. DNA has more than 3.8 million subscriptions in its fixed and mobile communications networks. The Group also includes DNA Store, Finland's largest retail chain selling mobile phones. DNA shares are listed on Nasdaq Helsinki Ltd. For further information, visit www.dna.fi or follow us on Twitter @DNA_fi, @DNA_Business and @DNA_Palvelu and Facebook.

 





This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of NASDAQ OMX Corporate Solutions clients. Source: DNA Plc, PO Box 10, Helsinki FI-01044, Finland
If you would like to unsubscribe and stop receiving these e-mails click here.